BiotechTube
Home/CorMedix/Danielle Hallock
DH

Danielle Hallock

General Counsel and Corporate Secretary

CorMedix

Therapeutic Areas

Infectious DiseaseNephrology

CorMedix Pipeline

DrugIndicationPhase
DefenCath (taurolidine/heparin)Prevention of Catheter-Related Bloodstream Infections (CRBSIs) in hemodialysis patientsPhase 3 / NDA Submitted

Leadership Team at CorMedix

JT
Joseph Todisco
Chief Executive Officer
MD
Matt David
Chief Financial Officer
JA
John Armstrong
Chief Development Officer
KS
Khosrow Sholehpour
Chief Commercial Officer
View full CorMedix profile